Hongyi Wu
180 Fenglin Road
Shanghai, 200032, China
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Calcitriol Suppresses Platelet Activation and Thrombosis, Mitigating Cardiovascular Risks in Metabolic Dysfunction-Associated Steatotic Liver Disease.
Journal: JACC. Basic to translational science
Published: January 08, 2026
Development and validation of a bleeding risk model for off-pump coronary artery bypass grafting: a multi-center retrospective cohort study.
Journal: International journal of medical informatics
Published: August 26, 2025
Thrombotic risk trajectories in patients with coronary artery disease before and during COVID-19.
Journal: iScience
Published: August 12, 2025
Efficacy and safety of bevifibatide in patients with acute coronary syndrome undergoing percutaneous coronary intervention (BES-PCI): A multicenter, randomized, double-blinded, placebo-controlled, phase III trial.
Journal: Chinese medical journal
Published: May 15, 2025
Indobufen Versus Aspirin Plus Clopidogrel in Patients After Coronary Stenting in Patients With Diabetes: A Post Hoc Analysis of the OPTION Trial.
Journal: Journal of diabetes
Published: April 29, 2025
ALDH2 rs671 variant enhances platelet activation and thrombosis by disrupting mitochondrial complex I assembly.
Journal: Cardiovascular research
Published: April 17, 2025
Metabonomic Biomarkers of Plaque Burden and Instability in Patients With Coronary Atherosclerotic Disease After Moderate Lipid-Lowering Therapy.
Journal: Journal of the American Heart Association
Published: December 10, 2024
The soluble guanylate cyclase (sGC) stimulator vericiguat inhibits platelet activation and thrombosis.
Journal: European journal of pharmacology
Published: December 10, 2024
20-HETE induced platelet activation via a GPR75-independent pathway.
Journal: Thrombosis research
Published: November 22, 2024
Indobufen-based dual antiplatelet therapy in patients with multivessel coronary disease undergoing drug-eluting stent implantation insight from the OPTION trial.
Journal: American heart journal
Published: October 11, 2024
Last Updated: 09/26/2026